Search
Sunday 31 January 2016
  • :
  • :

3 Best Stocks Under Review: Regions Financial (NYSE:RF), Valeant Pharmaceuticals Intl (NYSE:VRX), VMware, (NYSE:VMW)

On Thursday, Regions Financial Corp (NYSE:RF)’s shares declined -0.62% to $9.59. The market capitalization of Regions Financial Corp (NYSE:RF) is $12.53 billion with the total traded volume of the company is 9.62 million. Turning to market valuation, the Price-to-Earnings ratio is 13.91, the Price-to-Sales ratio is 3.52 and the Price-to-Book ratio is finally 0.79. The dividend yield amounts to 2.50 percent and the beta ratio has a value of 1.96.

Regions Financial Corporation, together with its auxiliaries, provides banking and bank-related services to individual and corporate customers in the United States. Its Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending, in addition to equipment lease financing services.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares dropped -0.65% to $101.67.

Valeant Pharmaceuticals International, Inc. (VRX) declared that chairman and chief executive officer J. Michael Pearson will be on a medical leave of absence, effective /files/includes/todays-hot-stories-pfizer-nysepfe-emc-corporation-nyseemc-att-nyset-spirit-realty-capital-nysesrc-154687-right.js away. The company’s board of directors has created an Office of the Chief Executive Officer, which will comprise Robert Chai-Onn, Executive Vice President and General Counsel, Dr. Ari Kellen, Executive Vice President and Company Group Chairman, and Robert Rosiello, Executive Vice President and Chief Financial Officer, to serve in an interim capacity.

In addition, the Board of Directors has created a Committee to oversee and support the Office of the CEO and will comprise Robert A. Ingram, Lead Independent Director, G. Mason Morfit, President, ValueAct Capital, and Howard B. Schiller, former Chief Financial Officer for Valeant.

Valeant confirmed last week that Mr. Pearson had recently been hospitalized and was being treated for a severe case of pneumonia.

“Our thoughts are with Mike and his family,” said Robert Ingram. “Out of respect, we will be honoring his family’s request for privacy and will not be commenting further on his condition at this time.”

Valeant Pharmaceuticals International, Inc. develops manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer.

VMware, Inc. (NYSE:VMW)‘s shares dipped -0.81% to $56.57. VMware, Inc. (NYSE:VMW) is now worth about $23.82 billion. The share price has made a -0.51% loss in the past 5 days and has lost -32.86% since 2015 kicked off. Analysts are forecasting EPS growth of 2.21% for next fiscal year and 13.79% growth in the next 5 years. The stock trades with a beta of 1.09. The stock price is below by -27.32% as contrast to the average price over the last 200 days. The company has 84.30% gross margins.

VMware, Inc. provides virtualization infrastructure solutions in the United States and internationally. The company’s virtualization infrastructure solutions comprise a suite of products designed to deliver a software-defined data center (SDDC), run on industry-standard desktop computers and servers, and support a range of operating system and application environments, in addition to networking and storage infrastructures. Its solutions enable organizations to aggregate multiple servers, storage infrastructure, and networks together into shared pools of capacity.